Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The aim of the study is to evaluate the physical activity level and the factors affecting physical activity among young adults who are socially isolated due to coronavirus.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Exercise Habit and Factors Affecting Exercise Attendance | It was created by the researchers due to the fact that the existing surveys could not meet the pandemic period. It will be questioned whether the participants had exercise habits in the times before the pandemic. Possible reasons will be questioned according to the positive and negative answers. The answers of the questions are yes / no and they will not be scored. Frequency evaluation will be made according to the results obtained. | The assessment will be made once at baseline, data collection will be completed up to 6 weeks. |
| Measure | Description | Time Frame |
|---|---|---|
| International Physical Activity Questionnaire - Short Form (IPAQ-SF) | IPAQ-SF provides information on walking, moderate and vigorous activities and time spent sitting, within a week. There are two forms of output from scoring the IPAQ. Results can be reported in categories (low activity levels, moderate activity levels or high activity levels) or as a continuous variable (MET minutes a week). MET minutes represent the amount of energy expended carrying out physical activity. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Young Adults from Community Sample
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Ayşe Zengin Alpözgen, PhD | Istanbul University - Cerrahpasa | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Özge Ertan | Istanbul | 34500 | Turkey (Türkiye) |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D012934 | Social Isolation |
| D009043 | Motor Activity |
| D018352 | Coronavirus Infections |
| ID | Term |
|---|---|
| D012919 | Social Behavior |
| D001519 | Behavior |
| D003333 | Coronaviridae Infections |
| D030341 | Nidovirales Infections |
Not provided
Not provided
Not provided
Not provided
Not provided
| The assessment will be made once at baseline, data collection will be completed up to 6 weeks. |
| Exercise Benefits/Barriers Scale | It was developed in response to a need for an instrument to determine perceptions of individuals concerning the benefits and barriers to participating in exercise. The scale, which is a 4-point Likert type, has 4 responses from 4 (strongly agree) to 1 (strongly disagree). The total score of the scale varies between 43-172. Higher scores mean that knowing the benefits of exercise and no barrier to exercise. | The assessment will be made once at baseline, data collection will be completed up to 6 weeks. |
| The Pittsburgh Sleep Quality Index | The Pittsburgh Sleep Quality Index (PSQI) is a self-report questionnaire that assesses sleep quality over a 1-month time interval. It consists of 24 questions, 18 of which are included in the scoring. Each question is scored between 0-3 and the highest total score is 21. The high total score indicates poor sleep quality. | The assessment will be made once at baseline, data collection will be completed up to 6 weeks. |
| The Hospital Anxiety and Depression Scale | A self-assessment scale has been developed and found to be a reliable instrument for detecting states of depression and anxiety. The questions of the scale, which is a 4-point Likert type, are scored between 0-3. The total score is obtained between 0-21. The high score indicates the presence of depression and anxiety. | The assessment will be made once at baseline, data collection will be completed up to 6 weeks. |
| D012327 |
| RNA Virus Infections |
| D014777 | Virus Diseases |
| D007239 | Infections |